4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-130499
Chief Technical Officer sold 12,941 shares at an average $50.00 ($647,114)
- Chief Technical Officer acquired 9,200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2023-12-27 | Option exercise 10b5-1 | +2,400 | $21.38 | $51,312 | 6,141 | D |
| Shulman Joseph Chief Technical Officer | 2023-12-27 | Sale 10b5-1 | −5,015 | $50.01 | $250,796 | 1,126 | D |
| Shulman Joseph Chief Technical Officer | 2023-12-28 | Option exercise 10b5-1 | +6,800 | $21.38 | $145,384 | 7,926 | D |
| Shulman Joseph Chief Technical Officer | 2023-12-28 | Sale 10b5-1 | −7,926 | $50.00 | $396,318 | 0 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2023-12-27 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,400 | 82,600 | D | ||
| Shulman Joseph Chief Technical Officer | 2023-12-28 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,800 | 75,800 | D | ||
| Open-market sales · 12,941 sh · avg $50.00 · $647,114 | |||||||
Loading xslF345X05/tm2333854-1_4seq1.xml…